drugset / Trial / NCT05658549
Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 Patients
RandomizedFactorialQuadruple-blindTreatment
Summary
This research is a study that compares the administration of N-acetylcysteine at various doses with the outcomes of COVID-19 patients, namely the neutrophil-to-lymphocyte ratio and length of stay.
Timeline
- Start
- 2021-05-01
- Primary completion
- 2021-07-30
- Completion
- 2021-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 200 mg | Oral |
| Subject | N-acetylcysteine | Small molecule | 400 mg | Oral |
| Subject | N-acetylcysteine | Small molecule | 1200 mg | Oral |